Last reviewed · How we verify
Gemtesa
At a glance
| Generic name | Gemtesa |
|---|---|
| Sponsor | University of Missouri-Columbia |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Vibegron for ENergy Thinking and Resilience in Aging (PHASE3)
- Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia (EARLY_PHASE1)
- Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |